Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG (NOVN)

275
Delayed Quote. Delayed CHI-X EUROPE LIMITED. - 07/03 05:20:04 pm
93.0750 CHF   -0.88%
07/02 Ergomed Appoints Andrew Mackie As Executive Director
07/02DJErgomed Appoints Andrew Mackie as Chief Business Officer
07/01 NOVARTIS : Alcon receives European Approval for pre-loaded intraocul..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
06/29/2015 06/30/2015 07/01/2015 07/02/2015 07/03/2015 Date
92.3(c) 92.15(c) 93.15(c) 93.9(c) 93.05(c) Last
6 095 131 6 948 423 6 959 220 3 951 836 3 004 064 Volume
-1.07% -0.16% +1.09% +0.81% -0.91% Change
More quotes
Financials ($)
Sales 2015 52 314 M
EBIT 2015 14 342 M
Net income 2015 13 365 M
Debt 2015 6 897 M
Yield 2015 2,86%
Sales 2016 53 595 M
EBIT 2016 14 784 M
Net income 2016 10 942 M
Debt 2016 4 536 M
Yield 2016 3,04%
PER 2015 16,01
PER 2016 21,90
EV / Sales 2015 5,18x
EV / Sales 2016 5,01x
Capitalization 264 095 M
More Financials
Company
Novartis AG develops, manufactures, and markets healthcare products.It operates through the following segments: Pharmaceuticals, Alcon, Sandoz, Vaccines and Diagnostics, and Consumer Health.The Pharmaceuticals segment provides patent-protected prescription medicines.The Alcon segment offers... 
Sector
Pharmaceuticals
Calendar
07/21Earnings Release
More about the company
Surperformance© ratings of Novartis AG
Trading Rating : Investor Rating :
More Ratings
Latest news on NOVARTIS AG
07/02 Ergomed Appoints Andrew Mackie As Executive Director
07/02 CATALENT : Makes Two Key European Appointments in Oral Dose Manufacturing
07/02DJErgomed Appoints Andrew Mackie as Chief Business Officer
07/02 INNOCOLL : Appoints Jose Carmona as Chief Financial Officer
07/02 Celldex Therapeutics Appoints Richard Wright as Chief Commercial Officer
07/01 NOVARTIS : "Compounds for the Treatment of Conditions Associated with Dgat1 Acti..
07/01 NOVARTIS : Hagens Berman: Class Action Alleges Novartis Gleevec Patent Infringem..
07/01 NOVARTIS : Spinifex Pharmaceuticals to be Acquired by Novartis
More news
Sector news : Pharmaceuticals - NEC
07/03 Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount
07/03 MALLINCKRODT : takes on FDA in fight over ADHD generic
07/03 KYOWA HAKKO KIRIN : Approval for ACOALAN in Japan
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07/02 SEEKING ALPHA'S BIOTECH WEEKLY : Celgene-Juno, Gilead's HIV NDA, Happy 4th!
07/01 CELGENE : The Juno Therapeutics Deal Is Worth The Premium
06/30 Deforestation Impacting Pharmaceutical Industry
06/30 Ouch! Feds want Novartis to fork over $3.4B to settle alleged False Claims Ac..
06/29 Novartis' secukinumab effective after one year of treatment for psoriatic art..


Comments 
Advertisement
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions